A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer.
Authors
Valsamo Anagnostou•Sara Moore•Janet Dancey
Journal
Journal of Clinical Oncology
Published
June 1, 2024
Sign in to comment
Add a comment...
Supporters
Support the authors with ResearchCoin
Topics
DOI
License
Unknown License
No comments yet. Start the conversation!
Your contribution could help open science.